| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
0.023 |
0.9 |
| mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |